Table 3.
Correlation between TLR3 expression and clinicopathologic characteristics in HCC.
| Item | N | Positive rate | P | Expressing pattern | P | |||
|---|---|---|---|---|---|---|---|---|
| + | % | M | P | M/P | ||||
| Age (year) | ||||||||
| ≤51.5 | 38 | 21 | 55.26 | >0.05 | 4 | 10 | 7 | >0.05 |
| >51.5 | 42 | 26 | 61.90 | 4 | 15 | 7 | ||
| Sex | ||||||||
| Male | 68 | 38 | 55.88 | >0.05 | 6 | 20 | 12 | >0.05 |
| Female | 12 | 9 | 75.00 | 2 | 5 | 2 | ||
| AFP (ng/mL) | ||||||||
| <400 | 64 | 42 | 65.63 | <0.05 | 6 | 22 | 14 | >0.05 |
| ≥400 | 16 | 5 | 31.25 | 2 | 3 | 0 | ||
| Tumor size | ||||||||
| <2 cm | 6 | 4 | 66.67 | >0.05 | 1 | 2 | 1 | >0.05 |
| 2–5 cm | 49 | 25 | 51.02 | 6 | 14 | 5 | ||
| >5 cm | 25 | 18 | 72.00 | 1 | 9 | 8 | ||
| Grade | ||||||||
| G1 | 8 | 6 | 75.00 | >0.05 | 0 | 6 | 0 | >0.05 |
| G2 | 33 | 21 | 63.64 | 4 | 10 | 7 | ||
| G3 | 39 | 20 | 51.28 | |||||
| HBsAg | ||||||||
| + | 22 | 19 | 86.36 | <0.05 | 2 | 16 | 1 | <0.05 |
| − | 58 | 28 | 48.28 | 6 | 9 | 13 | ||
| HBcAg | ||||||||
| + | 12 | 7 | 58.33 | >0.05 | 1 | 3 | 3 | >0.05 |
| − | 68 | 40 | 58.82 | 7 | 22 | 11 | ||
| Cirrhosis | ||||||||
| + | 42 | 36 | 85.71 | <0.05 | 5 | 20 | 11 | >0.05 |
| − | 38 | 11 | 28.95 | 3 | 5 | 3 | ||